Exploratory Study of the Digital Therapeutics CT-155 in the Treatment of People With Schizophrenia
Condition(s):SchizophreniaLast Updated:August 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:August 22, 2022Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:December 28, 2022Recruiting
Condition(s):Methamphetamine AbuseLast Updated:December 2, 2022Completed
Condition(s):Migraine; Episodic Migraine; Headache; Headache, MigraineLast Updated:March 8, 2024Active, not recruiting
Condition(s):Patellofemoral Pain SyndromeLast Updated:February 15, 2024Not yet recruiting
Condition(s):Mild Cognitive ImpairmentLast Updated:February 23, 2024Active, not recruiting
Condition(s):Migraine; Episodic Migraine; Headache; Headache, MigraineLast Updated:March 8, 2024Active, not recruiting
Condition(s):SchizophreniaLast Updated:March 15, 2024Recruiting
Condition(s):COPDLast Updated:April 27, 2017Unknown status
Condition(s):Drug Use Disorders; Illicit Drug Use; Alcohol-Related DisordersLast Updated:December 19, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.